Bpi B4 Fat Burner Side Effects #. Ni. Quitin 1. 4 mg transdermal patches. Summary of Product Characteristics (SPC)Ni. Quitin 1. 4 mg transdermal patches. Detox Beet Juice Side Effects - How To Detox After A Weekend Of Eating Detox Beet Juice Side Effects How Do You Detox Hair How Long To Detox From Vicodin. Each 1. 5 cm. 2 contains 7. For excipients, see section 6. Transdermal patch. Each patch is rectangular and is comprised of an outer matt pinkish tan- coloured layer, a middle silver layer and an outer clear layer which is removed prior to use. Ni. Quitin patches relieve and/or prevent craving and nicotine withdrawal symptoms associated with tobacco dependence. They are indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. Ni. Quitin patches are indicated in pregnant and lactating women making a quit attempt. If possible, when stopping smoking, Ni. Quitin patches should be used in conjunction with a behavioural support programme. Ni. Quitin patches should be applied once a day, at the same time each day and preferably soon after waking, to a non- hairy, clean, dry skin site and worn continuously for 2. The Ni. Quitin patch should be applied promptly on removal from its protective sachet. ![]() Learn about Chantix (Varenicline) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. As reviewed below, we have two studies in which Chantix failed to show statistical significance over nicotine patch in the percentage of successful long term quitters. Avoid applying to any skin which is broken, red or irritated. After 2. 4 hours the used patch should be removed and a new patch applied to a fresh skin site. The patch should not be left on for longer than 2. Skin sites should not be reused for at least seven days. Only one patch should be worn at a time. Patches may be removed before going to bed if desired. However use for 2. Concurrent behavioural support is recommended, as such programmes have been shown to be beneficial for smoking cessation. Adults 1. 8 years and over. Abrupt cessation of smoking: During a quit attempt every effort should be made to stop smoking with Ni. Quitin patches. Ni. Quitin therapy should usually begin with Ni. Quitin 2. 1 mg and be reduced according to the following dosing schedule: -Dose Duration Step 1 Ni. Quitin 2. 1 mg. First 6 weeks. Step 2 Ni. Quitin 1. Next 2 weeks. Step 3 Ni. Quitin 7 mg. Last 2 weeks. Light smokers (e. Step 2 (1. 4 mg) for 6 weeks and decrease the dose to Ni. Quitin 7 mg for the final 2 weeks. Patients on Ni. Quitin 2. Ni. Quitin 1. 4mg. This strength should then be continued for the remainder of the 6 week course before stepping down to Ni. Quitin 7mg for two weeks. If the symptoms persist the patient should be advised to seek the advice of a healthcare professional. For optimum results, the 1. Treatment with Ni. Quitin patch may be continued beyond 1. Further courses may be used at a later time, for Ni. Quitin patch users who continue or resume smoking. Gradual Cessation: For smokers who are unwilling or unable to quit abruptly. The 2. 1 mg patch can be used daily for 2- 4 weeks while the user continues to smoke as needed. At the end of the 2- 4 weeks the user should quit completely and continue using Step 1 2. Thereafter following the Step 2 and 3 directions for abrupt cessation above. Should the patient feel able to quit completely before their designated quit date they can do so. Reduction in smoking: For smokers who wish to cut down with no immediate plans to quit. A patch can be used while the user continues to smoke as needed. The user should reduce the number of cigarettes smoked as far as possible and to refrain from smoking as long as possible. Users should be encouraged to stop smoking completely as soon as possible. If users are still feeling the need to use the patches on a regular basis 6 months after the start of treatment and have still been unable to undertake a permanent quit attempt, then it is recommended to seek additional help and advice from a healthcare professional. Temporary Abstinence Apply a patch to control troublesome withdrawal symptoms including craving during the period when smoking is being avoided. Users should be encouraged to stop smoking completely as soon as possible. If users are still feeling the need to use the patches on a regular basis 6 months after the start of treatment and have still been unable to undertake a permanent quit attempt, then it is recommended to seek additional help and advice from a healthcare professional. Adolescents and children. Adolescents (1. 2 to 1. Where adolescents are not ready or not able to stop smoking abruptly, advice from a healthcare professional should be sought. Safety and effectiveness in children who smoke has not been evaluated. Ni. Quitin is not recommended for use in children under 1. Ni. Quitin is contraindicated in patients with hypersensitivity to the system, the active substance, or any of the excipients. Ni. Quitin patches should not be used by non- smokers, occasional smokers or children under 1. The risks associated with the use of NRT are substantially outweighed in virtually all circumstances by the well established dangers of continued smoking. Patients hospitalised for MI, severe dysrhythmia or CVA who are considered to be haemodynamically unstable should be encouraged to stop smoking with non- pharmacological interventions. If this fails, Ni. Quitin patches may be considered, but as data on safety in this patient group are limited, initiation should only be under medical supervision. Once patients are discharged from hospital they can use NRT as normal. If there is a clinically significant increase in cardiovascular or other effects attributable to nicotine, the nicotine patch dose should be reduced or discontinued. Diabetes: Blood glucose levels may be more variable when stopping smoking, with or without NRT as catecholamines released by nicotine can affect carbohydrate metabolism, so it is important for diabetics to monitor their blood glucose levels more closely than usual while using this product. Allergic reactions: Susceptibility to angioedema and urticaria. Atopic or eczematous dermatitis (due to localised patch sensitivity): In the case of severe or persistent local reactions at the site of application (e. Ni. Quitin and contact their physician. Contact sensitisation: Patients with contact sensitisation should be cautioned that a serious reaction could occur from exposure to other nicotine- containing products or smoking. A risk benefit assessment should be made by an appropriate healthcare professional for patients with the following conditions: • Renal and hepatic impairment: Use with caution in patients with moderate to severe hepatic impairment and/or severe renal impairment as the clearance of nicotine or its metabolites may be decreased with the potential for increased adverse effects.• Phaeochromocytoma and uncontrolled hyperthyroidism: Use with caution in patients with uncontrolled hyperthyroidism or phaeochromocytoma as nicotine causes release of catecholamines. Seizures: Potential risks and benefits of nicotine should be carefully evaluated before use in subjects taking anti- convulsant therapy or with a history of epilepsy as cases of convulsions have been reported in association with nicotine. Danger in small children: Doses of nicotine tolerated by adult and adolescent smokers can produce severe toxicity in small children that may be fatal. Products containing nicotine should not be left where they may be misused, handled or ingested by children. The patches should be folded in half with the adhesive side innermost and disposed of with care. Stopping smoking: Polycyclic aromatic hydrocarbons in tobacco smoke induce the metabolism of drugs catalysed by CYP 1. A2 (and possibly by CYP 1. A1). When a smoker stops this may result in a slower metabolism and a consequent rise in blood levels of such drugs. Transferred dependence: Transferred dependence is rare and is both less harmful and easier to break than smoking dependence. Safety on handling: Ni. Quitin is potentially a dermal irritant and can cause contact sensitisation. Care should be taken during handling and in particular contact with the eyes and nose avoided. After handling, wash hands with water alone as soap may increase nicotine absorption. No clinically relevant interactions between nicotine replacement therapy and other drugs has definitely been established, however nicotine may possibly enhance the haemodynamic effects of adenosine. Healthcare professionals are reminded that smoking cessation itself may require the adjustment of some drug therapy. Pregnancy. Stopping smoking is the single most effective intervention for improving the health of both the pregnant smoker and her baby, and the earlier abstinence is achieved the better.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2017
Categories |